Dermal Filler Market Report 2026

The dermal filler market size has grown rapidly in recent years. It will grow from $7.28 billion in 2025 to $8.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to rising cosmetic awareness, increasing availability of aesthetic treatments, growth in dermatology services, early introduction of injectable cosmetic solutions, growing beauty enhancement culture.

The dermal filler market size is expected to see rapid growth in the next few years. It will grow to $12.08 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing acceptance of medical aesthetics, rising aging population needs, growing spending on cosmetic care, strengthening demand for advanced filler formulations, expanding use in clinics and cosmetic centers. Major trends in the forecast period include rising demand for facial aesthetic enhancements, growing preference for non surgical cosmetic procedures, increasing use of fillers for anti aging treatments, rising popularity of minimally invasive beauty solutions, growing adoption of fillers for facial volume restoration.

An increasing number of aesthetic procedures performed by plastic surgeons is expected to drive the growth of the dermal filler market going forward. Aesthetic procedures refer to procedures that improve the face and body appearance. There has been a growing emphasis on the body and beauty for identity and self-expression. Dermal fillers are used majorly in plastic surgery or aesthetic procedures to help create a smoother and fuller appearance on the face. For instance, in June 2024, according to a report published by Aesthetic Society, a US-based professional organization, in 2023, the number of breast implant removal procedures increased to 74,326, up from 65,076 in 2022, reflecting a percentage change of 14.2%. Therefore, the increasing number of aesthetic procedures performed by plastic surgeons propels the growth of the dermal filler market.

Major companies operating in the dermal filler market are focusing on developing advanced formulations such as undereye hyaluronic acid (HA) dermal filler for market growth. Under-eye hyaluronic acid (HA) dermal filler refers to a gel-like injectable treatment specifically designed to restore volume, reduce hollowness, and minimize dark circles in the under-eye area, using hyaluronic acid to enhance hydration and achieve a natural appearance. For instance, in June 2023, Galderma, a Switzerland-based dermatology company, launched Restylane Eyelight, the first and only hyaluronic acid (HA) dermal filler in the U.S. using NASHA Technology. Offering results that can last up to 18 months, Restylane Eyelight provides a natural-looking enhancement with minimal crosslinking and a supportive gel texture that resists water absorption. Backed by a Phase 3 clinical study, it demonstrated that 87% of patients experienced reduced undereye hollowness after three months, with high satisfaction rates maintained over a year.

In July 2025, Waldencast plc, a UK-based beauty and wellness platform, acquired Novaestiq Corp. for an undisclosed amount. With this acquisition, Waldencast aims to expand its aesthetic-medicine offering, enabling its existing skincare brand to enter the U.S. injectable-dermal-filler market and thereby significantly broaden its addressable market. Novaestiq is a US-based medical-dermatology company that specializes in providing dermal filler.

Major companies operating in the dermal filler market report are Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma, Teoxane Laboratories, Laboratoires Vivacy, Croma-Pharma GmbH, Revance Therapeutics Inc., Bloomage Biotechnology Corporation Limited, Prollenium Medical Technologies Inc., Suneva Medical Inc., HansBiomed Co. Ltd., Medytox Inc., Regen Lab SA, BioPlus Co. Ltd., Bohus BioTech AB, Hyaltech Ltd., Bioxis Pharmaceuticals, Sculpt Fillers, Sylagen, Anika Therapeutics Inc., SciVision Biotech Inc., BioScience GmbH.

North America was the largest region in the dermal filler market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermal filler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dermal filler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dermal filler market consists of sales of autologous fat injections, permanent soft tissue filler. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.